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Abstract
Background: Vacuolar protein sorting 35 (VPS35), a key component of retromer, plays an important role in endosome-
to-Golgi retrieval of membrane proteins. Dysfunction of VPS35/retromer is a risk factor for neurodegenerative disorders,
including AD (Alzheimer’s disease) and PD (Parkinson’s disease). However, exactly how VPS35-deficiency contributes to
AD or PD pathogenesis remains poorly understood.
Results: We found that VPS35-deficiency impaired dendritic spine maturation and decreased glutamatergic transmission.
AMPA receptors, GluA1 and GluA2, are significantly reduced in purified synaptosomal and PSD fractions from VPS35-
deficient brain. The surface levels of AMPA receptors are also decreased in VPS35-deficient neurons. Additionally, VPS35
interacted with AMPA-type receptors, GluA1 and GluA2. Overexpression of GluA2, but not GluA1, could partially restore
the spine maturation deficit in VPS35-deficient neurons.
Conclusions: These results provide evidence for VPS35’s function in promoting spine maturation, which is likely through
increasing AMPA receptor targeting to the postsynaptic membrane. Perturbation of such a VPS35/retromer function may
contribute to the impaired glutamatergic transmission and pathogenesis of neurodegenerative disorders, such as AD and
PD.
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Background
Synapse formation, maintenance, and elimination are
critical for normal neurotransmission. In the early
stage of neurodegenerative diseases, such as Alzhei-
mer’s disease (AD) and Parkinson’s disease (PD), syn-
aptic neurotransmission is often defective. This
synaptic deficit appears to be an earlier deficit than
neuron-loss [1–3]. In AD patients, cognitive decline is
more likely to be correlated with the synaptic deficit
rather than neuronal-loss [2, 4]. Therefore, it is of
considerably interest to investigate how synapses are
altered in the course of neurodegenerative disorders.
Vacuolar protein sorting-35 (VPS35) is an important
component of the cargo-recognition retromer complex
that contains VPS35, VPS29 and VPS26 [5–7]. The ret-
romer complex is in charge of sorting cargos into re-
trieval pathway from endosome to Golgi apparatus
[5–7]. Recently, several lines of evidence implicate this
cargo-recognition complex together with SNX27 and
WASH complex in endosome-to cell surface recycling of
membrane receptors [8, 9]. Retromer is also found to me-
diate fast, local delivery of β2-adrenergic receptors
(β2ARs) from endosomes to the dendritic plasma mem-
brane [10].
VPS35/retromer dysfunction appears to be a risk fac-
tor for neurodegenerative disorders, including AD and
PD. [11–16] In late-onset AD patients, VPS35 level is
lower in hippocampal region [14]. Hemizygous deletion
of VPS35 enhances AD-like neuropathology in Tg2576
mouse model of AD [17]. VPS35 (also called PARK17)
mutations are identified in autosomal dominant PD pa-
tients [11, 12]. VPS35 level is also decreased in substan-
tia nigra of PD patients [18]. Recently, using VPS35
deficient mouse models, including VPS35 heterozygotes
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and selective deletion of VPS35 in dopamine neurons,
we have demonstrated that loss of VPS35 function in
dopamine neurons results in PD-relevant neuropathol-
ogy [15, 16]. While these observations support the view
for VPS35-deficiency as a risk factor for AD and PD, the
underlying molecular pathological mechanisms appear
to be a complex. Intriguingly, impaired postsynaptic glu-
tamatergic neurotransmission has been detected in
young adult VPS35-deficient hippocampus [17], and
transient suppression of VPS35 expression in developing
hippocampal neurons results in abnormal dendritic
spines [19]. These observations suggest that VPS35 may
play a role in spine formation and function, which may
underlie VPS35-prevention of AD pathogenesis.
In this paper, we further investigated VPS35’s function
in neuronal spine formation and maturation in culture
and in vivo. We provided morphological and electro-
physiological evidence for VPS35-deficiency to contrib-
ute to the spine deficit. In addition, VPS35 interacted
with AMPA receptors (AMPARs), and VPS35-deficiency
impaired AMPAR, particularly GluA1, surface targeting.
Furthermore, expression of GluA2, but not GluA1, par-
tially restored the spine deficit due to VPS35-deficiency.
Taken together, our results suggest that VPS35 plays a
crucial role in regulating AMPA receptor trafficking,
which may underlie its function in promoting spine mat-
uration and glutamatergic neurotransmission, revealing
a molecular mechanisms by which VPS35/retromer in
hippocampal neurons prevents AD-neuro-pathogenesis.
Results
Spine maturation deficit in VPS35-deficient brain
By taking advantage of VPS35 heterozygous mice
(VPS35+/m) that have the lacZ gene knocked-in into
VPS35 gene, resulting in a 50 % reduction of VPS35 pro-
teins [17, 20], we preformed Golgi staining analysis of
neuronal dendritic spines in VPS35+/+ (WT controls)
and VPS35+/m mice (4 months old). Golgi staining ana-
lysis showed that the spine densities of both apical and
basal dendrites of CA1 pyramidal neurons were reduced
in VPS35+/m hippocampus, compared with that of WT
controls (Figs. 1a, b). Further examining mature and im-
mature spines (revealed by spine morphology as illus-
trated in Fig. 1c) demonstrated an obvious reduction of
mature spines in VPS35-deficient CA1 hippocampal
neurons (Fig. 1a, b). No difference was observed in spine
density or morphology in cortical layer 2 pyramidal neu-
rons between VPS35+/+ and +/m brain (Fig. 1d, e). In
contrast, the spine density reduction was detected in
cortical layer 5 pyramidal neurons of VPS35+/m brain
(Fig. 1f, g). Based on β-Gal reporter analysis of VPS35
+/m brain, VPS35 was expressed in large in the cortical
layer 5 and hippocampal CA1-3 pyramidal neurons
(Fig. 1h, i) [17]. Thus, the region-selective spine deficit
appeared to be correlated well with VPS35’s expression
pattern.
Spine maturation deficit in VPS35-deficient neurons
We next addressed if VPS35 plays a cell autonomous
role in promoting spine maturation in cultured neurons.
The spine density and morphology were examined in
primary cultured VPS35+/+ and VPS35+/m hippocampal
neurons. The reduction of VPS35 level in VPS35+/m hip-
pocampal neurons was confirmed by immunostaining
analysis with VPS35 antibody (Additional file 1: Figure
S1A). The spine morphology and density were revealed
by the exogenous Synapsin promoter driven GFP-β-actin
(Synapsin-GFP-β-actin) in VPS35+/+ and VPS35+/m hip-
pocampal neurons (transfected at DIV 10, and imaged at
DIV 15). VPS35+/m hippocampal neurons displayed re-
duced spine numbers per 10 μm, compared with that of
WT control neurons (Fig. 2a, b). In particular, the ma-
ture spines such as mushroom spines were largely de-
creased (Fig. 2c). However, the number of filopodia-like
spines, which are usually considered as immature spines,
was increased in VPS35-deficient neurons (Fig. 2c). A
similar spine deficit was also detected in VPS35+/m hip-
pocampal neurons at DIV 18 by phalloidin staining,
which labels F-actin (Figs. 2d, e). Moreover, VPS35+/m
cortical neurons showed the similar spine defect (Add-
itional file 1: Figure S1B). These results provide add-
itional support for the necessity of VPS35 in neuronal
spine maturation, supporting the view for a cell autono-
mous role of VPS35 in promoting spine maturation.
Impaired glutamatergic transmission and decreased
excitatory synapses in VPS35-deficient CA1 hippocampus
The reduced excitatory spines in VPS35-deficient brain
may result in an impaired glutamatergic transmission.
To test this view, we recorded in whole-cell configur-
ation the miniature excitatory postsynaptic currents
(mEPSCs) from CA1 pyramidal neurons of 2-month-old
hippocampus (Fig. 3a). A significant reduction of the fre-
quency of mEPSCs in the mutant CA1 neurons was de-
tected (Fig. 3a and c), in agreement with results from
Golgi staining analysis that showed a reduced spine
density in VPS35+/m hippocampus (Fig. 1). In addition,
the amplitude of mEPSCs was also reduced in the CA1
pyramidal neurons from VPS35+/m brain, as compared
with the WT controls (Fig. 3a, b). Note that the fre-
quency of mEPSC was also lower in the mutant CA1
than that of WT controls (Fig. 3c), implicating a reduced
presynaptic vesicular glutamate release, or a decreased
numbers of synapse. Given the fact that paired-pulse fa-
cilitation (PPF) ratio was unchanged in the VPS35+/m
hippocampus [17], which indicates normal probability of
presynaptic vesical release, the reduced frequency may
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Fig. 1 (See legend on next page.)
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be due to a reduction in the numbers of excitatory
synapses of mutant hippocampal neurons.
We thus further analyzed the number of synapses in
the hippocampus by transmission electron microscopy
(EM). The excitatory synapse was indeed decreased in
VPS35+/m hippocampus, compared with that of WT con-
trols (Fig. 3d, e). No significant change in the inhibitory
synapses was detected in the mutant hippocampus
(Fig. 3d, e). The PSD (post-synaptic density) length and
thickness appeared also normal without obvious differ-
ence (Fig. 3f ). Interestingly, an increase in the number of
vesicles per synapse in the mutant hippocampus was ob-
served (Fig. 3g). As no difference is observed in the ratio
of PPF between VPS35+/+ and VPS35+/m CA1 pyramidal
neurons [17], these increased numbers of vesicles may
be non-releasable/functional vesicles. This view was fur-
ther supported by the observation that the vesicle
numbers near the active zone in a 200 nm*200 nm
square (indicated in yellow in Fig. 3d) in the mutant
hippocampus were comparable to that of WT controls
(Fig. 3d, h). Taken together, these results support the
view for VPS35 expression in hippocampal pyramidal
neurons to be critical for the excitatory spine maturation
and glutamatergic neurotransmission.
Reduced AMPA receptors and decreased AMPA receptor
cell surface distribution in VPS35-deficient brain and
neurons
To understand how VPS35 regulates glutamatergic
neurotransmission and excitatory synapse/spine matur-
ation, we examined protein levels of synapse-associated
proteins in purified synaptosomal and PSD fractions
from VPS35+/+ and VPS35+/m cortex. Interestingly,
GluA1 and GluA2 levels were reduced in both
Fig. 2 Reduced mature spines in VPS35+/m neurons. a Reduced spine density and altered spine morphology in Synapsin-GFP-Actin transfected primary
hippocampal neurons from VPS35+/m mice compared with VPS35+/+ controls. Primary hippocampal neurons transfected with Synapsin-GFP-Actin at DIV7
were fixed at DIV15. Top, representative images. Bottom, amplified images. Scale bars, 5 μm. b Quantification of spine density and spine morphology in A.
Data were shown as mean ± SEM; n= 30 neurons from 3 independent experiments; *p< 0.05. c Reduced spine density in primary VPS35+/m hippocampal
neurons viewed by phalloidin staining analysis. Primary hippocampal neurons were fixed at DIV18 and stained with phalloidin. Scale bars, 5 μm.
d Quantification of spine density in C. Data were presented as mean ± SEM; n= 30 neurons from 3 independent experiments; *p< 0.05
(See figure on previous page.)
Fig. 1 Reduced mature spines in VPS35+/m hippocampus and cortex. a Reduced mature spines in both apical and basal dendrites of CA1 region
from VPS35+/m mice at age of 4-months old by Golgi staining analysis. Top, representative lower power images. Bottom, higher power images of
apical dendrites from CA neurons. Scale bars, 5 μm. b Quantification of spine density and spine morphology in CA1 basal and apical dendrites
viewed by Golgi staining analysis. Data shown were mean ± SEM; n = 20 neurons; *p < 0.05. c Illustration of 4 different types of spines (mushroom,
thin, stubby, and filopodia) based on their morphology. The mushroom spines were defined as mature spines, and the other three types of spines
were defined as immature spines. d, e No difference in spine density and morphology in cortical layer 2 neurons between WT and VPS35+/m mice
at age of 4-months old. Scale bars, 5 μm. D, representative images of Golgi staining analysis; and E, quantification analysis. Data were shown as
mean ± SEM; n = 20 neurons; *p < 0.05. f, gReduced mature spines in both apical and basal dendrites of cortical layer 5 from 4 months old VPS35
+/m mice. F, representative images. Scale bars, 5 μm. G, quantification analysis. Data were shown as mean ± SEM; n = 20 neurons; *p < 0.05. h
Detection of β-Gal activity (blue color) in VPS35+/m cortical layer 5 at age of 3-months old. Layers I-VI were indicated. Left, Representative X-gal
staining images. Right, Amplified images of cortical layer 5 from VPS35+/m brain. Scale bars, 100 μm
Tian et al. Molecular Brain  (2015) 8:70 Page 4 of 12
synaptosomal and PSD fractions of VPS35+/m cortex,
compared with WT controls, by Western blot analysis
(Fig. 4a-c). A slight decrease in PSD95, the postsynaptic
marker of excitatory synapse, was also detected (Fig. 4).
No change in gephyrin level, a postsynaptic marker of
inhibitory synapse, was observed (Fig. 4). In contrast, the
synapsin-1, a presynaptic marker, was increased in syn-
aptosomal fractions of VPS35+/m cortex, compared with
WT controls (Fig. 4), in line with the increased numbers
of synaptic vesicles by EM studies.
Both GluA1 and GluA2 are AMPARs, which are
largely distributed in the postsynaptic membrane of exci-
tatory synapse [21–24]. We thus further examined
AMPARs’ distribution in cultured neurons from WT
and VPS35+/m brain. The exogenous GFP-GluA1 and
GFP-GluA2 were used to view GluA1 and GluA2 distribu-
tion in WT and VPS35+/m hippocampal neurons (trans-
fected at DIV 10, and imaged at DIV 15), respectively.
Indeed, the spine density labeled by GFP-GluA1 puncta
was also less in VPS35-deficient neurons (Fig. 5a, b), pro-
viding additional evidence for VPS35-deficiency in neu-
rons to cause an impaired spine maturation. However, this
spine deficit was not obvious in VPS35+/m neurons ex-
pressing GFP-GluA2 (Fig. 5c). Interestingly, the surface
distributions of GFP-GluA1 (labeled by GFP antibody
under non-permeable condition), in particularly at the
spine sites, were reduced in VPS35-deficient neurons
(Fig. 5a, b). We further examined whether endogenous
GluA1/A2’s cell surface distribution in VPS35+/m cortical
neurons is reduced by cell surface biotinylation assay. The
Fig. 3 Impaired glutamatergic transmission, reduced excitatory synapses, and increased vesicles per synapse in hippocampus of VPS35+/m mice. a
Representative traces of mEPSCs in CA1 pyramidal neurons from VPS35+/+ and VPS35+/m mice. Scale bar, 2 s, 10 pA. b Histograms of mEPSC
amplitude. n = 15 neurons from 3 mice for each genotype. Student’s t test, *p < 0.05. c Histograms of mEPSC frequency. n = 15 neurons from 3 mice
for each genotype. Student’s t test, *p < 0.05. d Decreased number of excitatory synapses and increased number of vesicles per synapse in 4-months
old VPS35+/m hippocampus. Top, representative transmission electron microscopic (TEM) images. Red arrows indicate excitatory synapse. Green arrows
indicate inhibitory synapse. Scale bar, 200 nm. Bottom, Close up view of one excitatory synapses. e-h Quantification analyses of number of synapses
(e), PSD length (f), number of vesicles per synapse(G), and vesicle density in 200 nm*200 nm square shown in yellow color near active zone in D (h).
Data were shown as mean ± SEM; n = 30 images from 3 mice per genotype; *p < 0.05
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cell surface levels (over total level) of GluA1 and GluA2
were lower in primary neurons from VPS35+/m brain than
that of VPS35+/+ controls (Fig. 5e, f ). These results suggest
that VPS35-deficiency in neurons impairs AMPAR surface
distribution.
To understand how VPS35 regulates AMPAR traffick-
ing, we asked whether AMPARs (GluA1 and GluA2)
interact with VPS35 and are cargos of retromer. Indeed,
both GFP-GluA1 and GFP-GluA2 were co-localized with
endogenous VPS35 in hippocampal neurons, particularly
in the shaft of dendrites (Additional file 2: Figure S2A-
S2B). GFP-GluA1 was also detected in the Flag-tagged
VPS35 immunoprecipitated complex in HEK293 cells
(Additional file 2: Figure S2C). These results support the
view for AMPAR (e.g., GluA1) as a cargo of VPS35/
retromer.
Restoration of the spine maturation deficit by expression
of GFP-GluA2, but not GFP-GluA1, in VPS35-deficient
neurons
Note that impairment of AMPARs’ insertion into post-
synaptic membrane can affect spine maturation [25–27].
We thus wonder if the impaired GluA1 or A2 targeting
to the cell surface may result in the deficit of spine mat-
uration in VPS35-deficient neurons. To address this
issue, GFP-GluA1 or GFP-GluA2 was transfected into
cultured VPS35+/+ and +/m hippocampal neurons
(DIV10). Neurons (at DIV 15) were fixed, stained with
phalloidin, and imaged both GFP and phalloidin fluores-
cence. Remarkably, the spine deficit (e.g., reduced
mature spines) due to VPS35-deficiency was restored by
expression of GFP-GluA2, but not GFP-GluA1 (Fig. 6a-
c). These results suggest that the impaired GluA2 target-
ing may be responsible for the spine deficit in VPS35-
deficient neurons.
Discussion
The retromer dysfunction is implicated as a risk factor
for the pathogenesis of neurodegenerative disorders, in-
cluding AD and PD [11–16]. The underlying patho-
logical mechanisms appear to be a complex. In this
study, we showed that VPS35 regulates GluA1 and
GluA2 cellular trafficking (Figs. 5 and 6), and loss of
VPS35 function leads to a decrease of cell surface level
of GluA1/A2 (Fig. 5), a reduction of glutamatergic
neurotransmission (Fig. 3a-c), and an impairment of ex-
citatory synapse/spine maturation (Fig. 3d-h). Expression
of GluA2, but not GluA1, partially restore the spine def-
icit in VPS35-deficient neurons (Fig. 6). Together, our
work leads to a working model (depicted in Fig. 6c) that
VPS35-deficiency results in an impaired GluA1/A2 cell
surface distribution, which may contribute to the re-
duced neuronal spine maturation and decreased gluta-
matergic synaptic transmission. This event may also
underlie the pathogenesis of neurodegenerative
disorders.
Dendritic spines are small actin-rich protrusions that
form the postsynaptic part of most excitatory synapses
[28]. They are highly dynamic structures and play crucial
roles in synaptic functions during learning and memory
Fig. 4 Reduced synapse associated GluA1 and GluA2 proteins in VPS35-deficient brain. a The glutamate receptor subunits GluA1 and GluA2’s
levels were decreased in both synaptosomal and PSD fractions from 3-months old VPS35+/m mouse brains. b, c Quantification of relative synapse
associated protein levels in synaptosomal fraction (b) and PSD fraction (c). Data were presented as mean ± SEM; n = 3; *p < 0.05
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[28, 29]. We report initially that VPS35 depletion in
CA1 neurons by in utero electroporation of miRNA-
VPS35 results in a loss of dendritic spines [19]. Here we
provide additional evidence for reduced dendritic spines
in young adult VPS35-deficient brain and in VPS35-
deficient neurons in culture (Figs. 1 and 2). VPS35/retro-
mer regulation of the dendritic spines is of the following
characteristics. First, VPS35 is crucial for spine matur-
ation, as the loss of dendritic spines is largely associated
with the decrease of mature spines. Second, VPS35 regu-
lation of spine maturation/dynamics appears to be a cell
autonomous event, as it is in a brain region and cell type
dependent manners and correlates well with VPS35’s ex-
pression pattern. This view is also supported by the ob-
servation that selectively knocking down of VPS35
expression in CA1 neurons leads to the spine deficit
[19].
Although it is unclear exactly how VPS35 regulates
dendritic spine maturation/dynamics, the decreased den-
dritic spines may be due to a defective AMPA receptor
protein trafficking and/or actin remodeling in VPS35 de-
ficient pyramidal neurons. Indeed, retromer/VPS35 is
implicated in GluA1 and GluA2 receptor trafficking,
since it interacts with AMPA receptors [30], and AMPA
Fig. 5 Decreased cell surface levels of GluA1 and GluA2 receptors in VPS35-deficient neurons. a, b Reduced surface GFP-GluA1 in VPS35+/m hippocampal
neurons. Both VPS35+/+ and VPS35+/m hippocampal neurons were transfected with GFP-GluA1 at DIV7. The surface GFP-GluA1 was labeled by GFP
antibody (monoclonal) under non-permeabilizing conditions (no Triton X-100) at DIV 15, then the neurons were fixed. The total GFP-GluA1 were labeled
by GFP antibody (polyclonal) after permeablized by Triton X-100. A, representative imunnostaining images. Scale bars, 5 μm. B, quantification of surface to
total GFP-GluA1 in A. Data were shown as mean ± SEM; n= 30 neurons from 3 independent experiments; *p< 0.05. c, d Reduced surface GFP-GluA2 in
VPS35+/m hippocampal neurons. As GFP-GluA1, GFP-GluA2 was transfected into VPS35+/+ and VPS35+/m hippocampal neurons at DIV7. The surface and
total GFP-GluA2 were labeled by GFP antibody as described above. C, representative imunnostaining images. Scale bars, 5 μm. D, quantification of surface
to total GFP-GluA2 in C. Data were shown as mean ± SEM; n= 30 neurons from 3 independent experiments; *p< 0.05. e, f Reduced cell surface level of
GluA1 and GluA2 in VPS35+/m cortical neurons by biotinylation assay. E, representative blots; F, quantification of surface over total receptors (ratio) in E. Data
were presented as mean ± SEM; n= 3; *p< 0.05
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receptor targeting to the cell surface is impaired (Fig. 5).
The retromer/VPS35 is also implicated in actin dynam-
ics, as it interacts with WASH protein complex [31–34],
an important complex for actin remodeling, receptor
endocytosis, and tubulin cross talk [35, 36]. Thus, it is
conceivable that loss of VPS35 function may results in a
combination of impairments in both AMPA receptor
trafficking and WASH1 mediated actin remodeling in
dendrites, leading to a reduction in dendritic spine dens-
ity and maturation. However, this speculation requires
further investigation.
The VPS35+/m brain display an impairment in AMPA
receptor-mediated synaptic transmission, which is likely
due to a loss of excitatory synapses and a decrease of
glutamatergic synaptic activity. Our data corroborate
with the view that AMPA receptors, the homo- or het-
erotetramers of a combination of two of the GluA1-A4
subunits, are the principle ionotropic glutamate-gated
receptors mediating excitatory synaptic transmission in
the brain [21–24]. How does VPS35/retromer regulate
the excitatory synapse numbers and glutamatergic post-
synaptic activity? Our studies in cultured neurons
showed a reduced cell surface targeting of AMPA recep-
tors (GluA1 and A2) due to VPS35 deficiency (Fig. 5).
Expression of GluA2, but not GluA1, in VPS35-deficient
neurons partially restored the dendritic spine deficit
(Fig. 6). These observations support the view that AMPA
receptor trafficking, particularly GluA2, may be critical
for dendritic spine maturation.
Our observation of the reduced cell surface targeting
of AMPA receptors is in line with the report by Choy et
al., that retromer knockdown decreases functional ex-
pression of both AMPA and NMDA receptors at synap-
ses [10]. However, it is different from the report that
expression of the PD-linked mutation (D620N) in
VPS35 results in an increased GluR1 cell surface
Fig. 6 Restoration of the spine deficit of VPS35+/m hippocampal neurons by expression of GluA2, but not GluA1. a-c Both VPS35+/+ and VPS35+/m
hippocampal neurons transfected with GFP-GluA1 or GFP-GluA2 at DIV7 were fixed at DIV 15 and stained with phalloidin. a, b, representative images. Scale
bars, 5 μm. c Quantification of spine density in A-B. Data were shown as mean ± SEM; n= 30 neurons from 3 independent experiments; *p< 0.05. d A
working model for VPS35-deficiency induced deficits of AMPA receptor trafficking, glutamatergic transmission, and dendritic spine maturation
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distribution [30]. These different results suggest that the
D620N mutation may behave as a gain of function mu-
tant in this event. However, it remains to be determined
if the mutation results in an increased glutamatergic
transmission in vivo.
Conclusion
In aggregate, the results presented here suggest a critical
role of VPS35/retromer in regulating AMPA receptor
trafficking and dendritic spine maturation, which may be
critical for retromer regulation of glutamatergic trans-
mission. Dysregulation of this function may contribute
to the impaired glutamatergic transmission associated




Rabbit polyclonal anti-vps35 antibody was generated by
using the antigen of GST–VPS35D1 fusion protein as
described [14, 17]. Rabbit polyclonal anti-Synapsin 1a/1b
(Santa Cruz), GluR1 (Millipore), GFP (Santa Cruz) anti-
bodies and mouse monoclonal anti-PSD95 (Millipore),
GluR1 (Millipore), GluR2 (Millipore), β-actin (Upstate),
Flag (Sigma), and TfR (Abcam) antibodies were used.
VPS35 mutant mice were generated by injection of
mutant embryonic stem (ES) cells obtained from Bay
Genomics as described previously [17, 20]. All experi-
mental procedures were approved by the Animal Sub-
jects Committee at the Georgia Regents University,
according to US National Institutes of Health guidelines.
Expression vectors
The shRNA-VPS35 expression vector was generated by
the pSuper vector system, and the miRNA- VPS35 ex-
pression vector was generated by the BLOCK-iT Lenti-
viral miR RNAi expression system (Invitrogen)
according to the manufacturer’s instructions [17, 37].
The cDNAs encoding full length VPS35 were amplified
by PCR and subcloned into mammalian expression vec-
tors downstream of a signal peptide and a Flag epitope
tag (MDYKDDDDKGP) and under control of the cyto-
megalovirus promoter [38, 39]. The plasmids of GFP-
tagged GluA1 and GFP-GluA2 were a gift given by Dr.
Richard Huganir (Johns Hopkins University). The plas-
mid of Synapsin-GFP-actin was a gift given by Dr. Lin
Mei (Georgia Regents University). The authenticity of all
constructs was verified by DNA sequencing and West-
ern blot analysis.
Staining
Golgi staining was performed by using the FD Rapid
GolgiStain Kit following the manufacturer’s protocal (FD
NeuroTechnologies). Spines were counted on secondary
and tertiary branches of apical and basal dendrites in the
CA1 hippocampal and cortical region individually. 20
segments of either secondary or tertiary dendrites were
randomly selected. Dendrites length was measured using
ImageJ.
β-Gal detection
VPS35+/+ or VPS35+/m mouse was perfused with 2 %
paraformaldehyde and 0.2 % glutaraldehyde in PBS buf-
fer. Brain was removed and post-fixed in the same buffer
for 1 h at 4 °C. Sections (30 μm) were incubated in X-gal
buffer (2 mM MgCl2, 5 mM potassium ferricyanide,
5 mM potassium ferrocyanide, and 0.1 % X-gal) avoid
light at 37 °C for 12 h, washed and mounted in Per-
mount. Images were required by deconvolution digital
microscope (Axioplan 2; Carl Zeiss).
Electrophysiological recording
Hippocampal slices were prepared as described previ-
ously (15). After anesthetized with ketamine/xylazine
(Sigma, 100/20 mg/kg, respectively, ip), Mice (2 month-
old, male) were sacrified, brains were quickly removed
into ice-cold modified artificial cerebrospinal fluid
(ACSF) containing (in mM): 250 glycerol, 2 KCl, 10
MgSO4, 0.2 CaCl2, 1.3 NaH2PO4, 26 NaHCO3, and 10
glucose. Coronal hippocampal slices (300 μm) were cut
in ice-cold modified ACSF using a VT-1000S vibratome
(Leica, Germany) and transferred to a storage chamber
containing regular ACSF (in mM) (126 NaCl, 3 KCl, 1
MgSO4, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10
glucose) at 34 °C for 30 min and at room temperature
(25 ± 1 °C) for additional 1 h before recording. All solu-
tions were saturated with 95 % O2 /5 % CO2 (vol/vol).
Slices were placed in the recording chamber, which
was superfused (2 ml/min) with ACSF at 32–34 °C. CA1
pyramidal neurons were visualized with infrared optics
using an upright microscope equipped with a 40x water-
immersion lens (Axioskop 2 Plus, Zeiss) and infrared-
sensitive CCD camera (C2400-75, Hamamatsu). The Pi-
pettes were pulled by a micropipette puller (P-97, Sutter
instrument) with a resistance of 3–5 MΩ. Recordings
were made with MultiClamp 700B amplifier and 1440A
digitizer (Molecular Device). For miniEPSC (mEPSC) re-
cording, pyramidal neurons were holded at −70 mV in
the presence of 20 μM BMI and 1 μM TTX, with the
pipette solution containing (in mM): 125 Cs-
methanesulfonate, 5 CsCl, 10 Hepes, 0.2 EGTA, 1
MgCl2, 4 Mg-ATP, 0.3 Na-GTP, 10 phosphocreatine and
5 QX314 (pH 7.40, 285 mOsm). Series resistance was
controlled below 20 MΩ and not compensated. Cells
would be rejected if membrane potentials were more
positive than −60 mV; or if series resistance fluctuated
more than 20 % of initial values. All recordings were
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done at 32–34 °C. Data were filtered at 1 kHz and sam-
pled at 10 kHz.
Electron micrograph
4 months old mouse were perfused with 4 % paraformal-
dehyde and 2 % glutaraldehyde in 100 mM sodium
phosphate buffer (pH 7.4), then brain was removed and
post-fixed in the same buffer overnight at 4 °C. Hippo-
campus excised from the brain was post-fixed in 2 % os-
mium tetroxide in NaCac, then stained en bloc with 2 %
uranyl acetate, and dehydrated with graded ethanol, em-
bedded with Epon-Araldite resin. Ultrathin sections were
prepared by a Leica EM UC6 ultramicrotome (Leica
Microsystems) and stained with uranyl acetate and lead
citrate. Prepared sections were examined by a JEM 1230
transmission electron microscope (JEOL. USA) at
110 kV with an UltraScan 4000 CCD camera & First
Light Digital Camera Controller (Gatan). 30 EM images
per mouse were randomly picked and analyzed by inves-
tigators unaware of genotypes. Synapses were defined by
having alignment of presynaptic and postsynaptic mem-
branes, presynaptic and postsynaptic thickness, and a
bunch of synaptic vesicles.
Immunofluorescence staining and confocal imaging
analysis
For immunofluorescence staining of cultured neurons,
primary cultured neurons on the coverslips were fixed
with 4 % paraformaldehyde at room temperature for
20 min, permeabilized in 0.2 % Triton X-100 for 10 min,
after washing with PBS for 3 times, incubated with 5 %
BSA in PBS at room temperature for 30 min, and then
were incubated with antibodies as previously de-
scribed at 4 °C overnight. After wash with PBS for 3
times, coverslips were incubated with Alexafluor-
conjugated secondary antibodies (1:500, Invitrogen) or
Alexafluor-conjugated phalloidin for 1 h at room
temperature. Coverslips were mounted with Vecta-
shield mounting medium (Vector). Confocal images
were acquired by Zeiss LSM510 confocal microscope
by using oil immersion 40 or 63 × objective.
Cell culture and transfection
HEK 293 cells were maintained in Dulbecco modified
Eagle medium (Cellgro) supplemented with 10 % fetal
bovine serum (Gembio) and 100U/ml penicillin G and
streptomycin (Invitrogen). Transient transfection was
performed using polyethylenimine (Aldrich cat. no.
40,872-7) as described [40]. Seventy two h after transfec-
tion, cells were subjected to further experiments.
Mouse hippocampal and cortical neurons were cul-
tured from hippocampi or cortices of E18-19 mouse em-
bryos or P0 VPS35+/+ or VPS35+/m mice as described
[37]. Briefly, tissues were digested in 0.25 % Trypsin at
37 °C for 20 min, then re-suspended in plating medium
(DMEM supplemented with 10 % FBS) and plated onto
poly-L-lysine coated coverslips in 12 well-plate at a
density of 5 × 104 or 1 × 105 per well for 4 h before re-
placing with maintenance medium (neural basal medium
supplemented with B27 and L-glutamax). Maintenance
medium was half changed every 3 days. Calcium phos-
phate method was used to transfect neurons at DIV7-10
as described [37], and at DIV 14–17, neurons were sub-
jected to immunocytochemistry.
Synaptosomal and PSD fractions preparation
Mouse hippocampi and cortices were homogenized on
ice in cold sucrose buffer (0.32 M sucrose and 25 mM
HEPES, pH 7.4), and were centrifuged at 500 g for
5 min. The supernatant (S1) were centrifuged at
10,000 g for 10 min to obtain supernatant (S2; light
membrane and cytosolic fraction) and the pellet (P2;
crude synaptosomal fraction). The P2 fraction was
washed twice with cold sucrose buffer and then re-
suspended in cold HBS buffer (25 mM HEPES, pH 7.4,
and 150 mM NaCl) to get the synaptosomal fraction.
For PSD fraction, samples were re-suspended in 1 % Tri-
ton HBS buffer at 4 °C for 30 min alternatively, and cen-
trifuged at 10,000 g for 20 min. Both synaptosomal and
PSD fractions were dissolved in 2D buffer (30 mM Tris
pH 8.5, 5 mM Magnesium Acetate, 8 M Urea, 4 %
CHAPS). Proteins were eluted with SDS sample buffer
by boiling for 5 min.
Co-immunoprecipitation
For in vitro co-immunoprecipitation, HEK 293 cells
transfected with different constructs were lysed in modi-
fied RIPA buffer (50 mM Tris pH7.5, 150 mM NaCl,
0.1 % TritonX-100, 10 % Glycerol, 1 mM NaF, 1 mM
PMSF and protein inhibitors) for 10 min at 4 °C, and ro-
tated at 4 °C for 1 h. After centrifugation at 13,000 rpm
for 10 min, 500 ul of supernantent from transfected cells
were incubated with 1 ul of mouse monoclonal anti-flag
antibody (Sigma) and 50 ul Protein G-Agarose (Roche)
at 4 °C overnight. Beads were washed three times with
Lysis buffer and eluted with SDS sample buffer by boil-
ing for 5 min followed by Western blot.
For in vivo co-immunoprecipitation, mouse hippo-
campi were homogenized in modified RIPA buffer
(50 mM Tris pH7.5, 150 mM NaCl, 0.1 % TritonX-100,
10 % Glycerol, 1 mM NaF, 1 mM PMSF and protein in-
hibitors) by a glass Teflon homogenizer, and rotated at
4 °C for 1 h. After centrifugation at 13,000 rpm for
10 min. 500 ul of brain lysates were incubated with 2 ul
of rabbit polyclonal anti-GluR1 antibody (Sigma) and 50
ul Protein A-Agarose (Roche) at 4 °C overnight. Beads
were washed three times and eluted with SDS sample
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buffer by boiling for 5 min with Lysis buffer followed by
Western blot.
Cell surface biotinylation assay
Transfected HEK 293 cells or primary cultured neurons
in 60 mm dish were first washed with ice cold PBS/CM
buffer (PBS containing 1 mM MgCl2 and 0.1 mM
CaCl2), and incubated with Sulfo-NHS-LC-Biotin in
PBS/CM buffer at 4 °C for 40 min. Washed once with
ice cold PBS/CM and incubated with 0.01 M glycine,
followed by three washes in ice cold PBS/CM. Cells were
harvested in RIPA buffer (50 mM Tris pH7.5, 150 mM
NaCl, 1 % TritonX-100, 0.02 % SDS, 1 mM PMSF and
protein inhibitors). After centrifugation at 13,000 rpm
for 10 min, the supernatant was incubated with 50 ul of
50 % avidin agarose (Thermo) with rotating overnight at
4 °C, followed by three washed with lysis buffer. Bound
proteins were eluted with SDS sample buffer by boiling
for 5 min. Total protein and isolated biotinylated pro-
teins were analyzed by immunoblotting.
Statistical analysis
All values were presented as mean ± SEM. Statistical
analysis were performed by Student’s T-test. The signifi-
cant level was set when p <0.05.
Additional files
Additional file 1: Figure S1. Decreased VPS35 and reduced mature
spines in VPS35+/m neurons. (A) VPS35 signal was reduced in primary
hippocampal neurons from VPS35+/m mouse compared with that of
VPS35+/+ controls. Primary hippocampal neurons were fixed at DIV15 and
stained with VPS35 antibody. Scale bars, 5 μm. (B) Spine density was
decreased and spine morphology was altered in Synapsin-GFP-actin
transfected primary cortical neurons from VPS35+/m mouse, compared
with that of VPS35+/+ controls. Primary cortical neurons transfected with
Synapsin-GFP-Actin at DIV7 were fixed at DIV15. Scale bars, 5 μm.
(TIFF 437 kb)
Additional file 2: Figure S2. VPS35 interaction with GluA1 and GluA2.
(A) Co-immunostaining analysis of endogenous VPS35 with GFP-GluA1/
GFP-GluA2 in cultured hippocampal neuron expressed GFP-GluA1/GFP-
GluA2. Scale bars, 5 μm. (B) Quantification of colocalization index (over-
lapping signal over total GFP) in A. Data were shown as mean ± SEM; n =
30 neurons from 3 independent experiments; *p < 0.05. (C) Coimmuno-
precipitation analysis of exogenously expressed flag-VPS35 and GFP-
GluA1. HEK293 cells transfected with indicated plamids were lysed and
subjected to co-immunoprecipitation assays. The resulting lysates were
loaded onto SDS-PAGE gels and immunoblotted with indicated anti-
bodies. (TIFF 14153 kb)
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